FDA Warns Companies Illegally Selling CBD Products
The U.S. Food and Drug Administration (FDA) has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that…
Regulations
Zealand Pharma Announces FDA Approval of Zegalogue (dasiglucagon)
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
Medicare Payment for COVID-19 Vaccination Increased
On March 15, the Centers for Medicare & Medicaid Services (CMS) is increasing the Medicare payment amount for administering the COVID-19 vaccine.“This new and higher…
FDA Permits Marketing of First SARS-CoV-2 Diagnostic Test
On March 17, the U.S. Food and Drug Administration (FDA) granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), the first SARS-CoV-2 diagnostic test…
CDC Requirements For Airlines To Avoid Ebola Spread
Starting Thursday, March 4, 2021, airlines and other aircraft operators will be required to collect and transmit contact information to Centers for Disease Control and…
FDA vs Fraudulent COVID-19 Products
On March 2, The U.S. Food and Drug Administration (FDA) announced about the beginning of the ‘National Consumer Protection Week,’ to encourage consumers and health…
FDA Issues EUA for Third COVID-19 Vaccine
On February 27, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus…
FDA Warns Companies for Selling Dietary Supplements
Recently the U.S. Food and Drug Administration (FDA) announced warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate,…
CDC’s Blueprint for Reopening Schools
The Centers for Disease Control and Prevention (CDC) on Friday urged that K-12 schools be reopened as soon as possible, and it offered a step-by-step…
Monoclonal Antibodies For Treatment of COVID-19
On the February 9, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab (monoclonal antibodies) administered together for…